PLAA抗体;PLAA Antibody—艾普蒂 新品

+ +

•  

   

     IHC-P analysis of testis tissue by PLAA antibody (P15358) IHC-P was performed using sections of the formalin-fixed paraffin-embedded testis tissue;Result: Spermatogonia and spermatocytes are positively stained at the nuclei.    

  
  

**Background of PLAA Antibodies**

Phospholipase A2-activating protein (PLAA) antibodies target PLAA, a conserved protein critical for cellular signaling and membrane homeostasis. PLAA facilitates the activation of phospholipase A2 (PLA2), an enzyme involved in releasing arachidonic acid from phospholipids, a precursor for pro-inflammatory mediators like prostaglandins and leukotrienes. This pathway links PLAA to inflammatory responses, neurodegenerative disorders, and cancer progression.

PLAA also plays a role in protein quality control via the ubiquitin-proteasome system, influencing cell survival and stress responses. Dysregulation of PLAA is implicated in diseases such as Parkinson’s, Alzheimer’s, and certain malignancies. Anti-PLAA antibodies are primarily used in research to study PLAA expression, localization, and function in pathological contexts.

In autoimmune diseases, PLAA autoantibodies have been detected, suggesting its potential as a biomarker. Studies explore their diagnostic relevance in conditions like systemic lupus erythematosus (SLE) or rheumatoid arthritis. However, their pathogenic role remains unclear. Current research focuses on PLAA's dual role in inflammation/proteostasis and therapeutic targeting, highlighting its importance in both basic and clinical contexts.